Article Text


Session title: Risk Assessment, Screening Tools and Infections in MSMsSession date: Thursday 28 June 2012; 11.30 am–1.00 pm
O21 Should we opportunistically treat rectal Chlamydia trachomatis infection in men who have sex with men presenting with non-specific urethritis?
  1. M Rayment1,
  2. L Bull1,
  3. S Mandalia2,
  4. F Boag1,
  5. N Nwokolo1,
  6. R Jones1
  1. 1Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
  2. 2Imperial College


Background Infection of the rectum with Chlamydia trachomatis (CT) is highly prevalent among men who have sex with men (MSM) attending our service (c. 8%). Our guidelines advise different antibiotics for the treatment of non-specific urethritis (NSU) (azithromycin 1 g as a single dose) and for rectal CT infection (doxycycline 100 mg twice daily for 7 days). MSM receiving treatment for NSU require recall if they are latterly found to have concurrent rectal CT. Should we therefore use doxycycline first line in MSM presenting with NSU?

Aims To determine the proportion of MSM diagnosed with NSU with rectal CT infection; to identify independent predictors of having rectal CT.

Methods The clinic database identified sequential MSM diagnosed with NSU over 6 months. Co-variables collected: age, sexual history, HIV status, contact history and the presence of rectal symptoms. Only men accepting rectal sampling were included. Univariate and multivariable logistic regression analyses were undertaken.

Results 566 MSM presenting with NSU were identified, of whom 130 (23%) were diagnosed with CT infection of at least one anatomical site. Of this group, 99 were included in the analysis. The overall prevalence of rectal CT infection was 38% (38/99). In men reporting a history of unprotected receptive anal intercourse (UPRAI) in the preceding 6 months, the prevalence was 61% (31/51); in those without it was 7.1% (14/48). In MSM reporting rectal symptoms, the prevalence was 90% (9/10); in those without: 33% (29/89). In the multivariable model, the only independent predictors of risk of rectal CT infection were UPRAI and rectal symptoms (see Abstract O21 table 1).

Abstract O21 Table 1

Rate of rectal chlamydia according to history and rectal symptoms

Discussion First line treatment of NSU in MSM could be modified based on the likelihood of concurrent CT infection. In men reporting UPRAI in the preceding 6 months, or reporting rectal symptoms, it would be reasonable to offer treatment of NSU with doxycycline. In all other patients, we propose continuing to use azithromycin first line, with subsequent recall for further treatment as necessary.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.